Menu
Menu
19 Harley St, London, W1G 9QJ, UK

Electrochemotherapy within the therapy of metastatic malignant melanoma: a potential cohort research by InspECT.

Related Articles

Electrochemotherapy within the therapy of metastatic malignant melanoma: a potential cohort research by InspECT.

Br J Dermatol. 2017 Jun;176(6):1475-1485

Authors: Kunte C, Letulé V, Gehl J, Dahlstroem Ok, Curatolo P, Rotunno R, Muir T, Occhini A, Bertino G, Powell B, Saxinger W, Lechner G, Liew SH, Pritchard-Jones R, Rutkowski P, Zdzienicki M, Mowatt D, Sykes AJ, Orlando A, Mitsala G, Rossi CR, Campana L, Brizio M, de Terlizzi F, Quaglino P, Odili J, InspECT (the Worldwide Community for Sharing Practices on Electrochemotherapy)

Summary
BACKGROUND: (ECT) is an efficient native therapy for cutaneous metastasis. Therapy entails the administration of chemotherapeutic medicine adopted by supply pulses to the tumour.
OBJECTIVES: To analyze the effectiveness of ECT in cutaneous metastases of melanoma and to establish elements that have an effect on (beneficially or adversely) the result.
METHODS: 13 most cancers centres within the Worldwide Community for Sharing Practices on Electrochemotherapy consecutively and prospectively uploaded information to a standard database. ECT consisted of intratumoral or intravenous injection of bleomycin, adopted by utility of electrical pulses below native or basic anaesthesia.
RESULTS: In whole, 151 sufferers with metastatic melanoma had been recognized from the database, 114 of whom had follow-up information of 60 days or extra. Eighty-four of those sufferers (74%) skilled an general response (OR = full response + partial response). General, 394 lesions had been handled, of which 306 (78%) confirmed OR, with 229 displaying full response (58%). In multivariate evaluation, elements positively related to general response had been protection of deep margins, absence of visceral metastases, presence of lymphoedema and therapy of nonirradiated areas. Elements considerably related to full response to ECT therapy had been protection of deep margins, earlier irradiation of the handled space and tumour dimension (< three cm). One-year general survival on this cohort of sufferers was 67% (95% confidence interval 57-77%), whereas melanoma-specific survival was 74% (95% confidence interval 64-84%). No critical opposed occasions had been reported, and the therapy was normally very properly tolerated.
CONCLUSIONS: ECT is a extremely efficient native therapy for melanoma metastases within the pores and skin, with no extreme opposed results famous on this research. Within the presence of sure medical elements, ECT could also be thought-about for native tumour management as an alternative choice to established native remedies, or as an adjunct to systemic remedies.

PMID: 28118487 [PubMed – indexed for MEDLINE]

Electrochemotherapy within the therapy of metastatic malignant melanoma a potential cohort research by InspECT | London private clinic

What our patients say ...

Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Surgeon
Consultant Spinal Anaesthetist

This surgical technique consists of a percutaneous approach for the treatment of small to medium size hernias of the intervertebral disc by laser energy. The main objective is to reduce the intradiscal pressure in the nucleus pulposus

Laser Disc Surgery can be performed under local anaesthetic as a day case at our centre on the prestigious Harley Street.
What is London spine unit and How it Works

The London Spine Unit was established in 2005 and has successfully treated over 5000 patients. All conditions are treated.

treatment of all spinal disorders

The London Spine Unit specialises in Minimally Invasive Treatments allowing rapid recovery and return to normal function

Trusted by patients worldwide

The London Spine Unit provides the highest quality care to all patients and has VIP services for those seeking exceptional services

If you have any emergency Doctor’s need, simply call our 24 hour emergency

Your personal case manager will ensure that you receive the best possible care.

Call Now 

+44 844 589 2020
+44 203 973 8810